Literature DB >> 6120197

Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolysaccharide of Neisseria gonorrhoeae P9.

P R Lambden, J E Heckels.   

Abstract

Oligosaccharide was isolated from the lipopolysaccharide of Neisseria gonorrhoeae P9 following partial acid hydrolysis. The exposed terminal keto-deoxyoctonic acid group of the oligosaccharide was convert into the reactive phenylisothiocyanato derivative by reaction with 2-(4-aminophenyl)-ethylamine followed by reduction with sodium cyanoborohydride and treatment with thiophosgene. This intermediate was used to prepare an oligosaccharide-protein conjugate with either bovine serum albumin or purified gonococcal pili. Immunisation of rabbits with protein conjugates produced antibodies reactive with both pure protein and intact lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120197     DOI: 10.1016/0022-1759(82)90197-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Coprecipitation of lipopolysaccharide and the 39,000-molecular-weight major outer membrane protein of Haemophilus influenzae type b by lipopolysaccharide-directed monoclonal antibody.

Authors:  P A Gulig; E J Hansen
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

2.  Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.

Authors:  C Y Chu; B K Liu; D Watson; S S Szu; D Bryla; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

3.  Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis.

Authors:  Tamara Al-Bader; Myron Christodoulides; John E Heckels; Judith Holloway; Amanda E Semper; Peter S Friedmann
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.

Authors:  H J Jennings; C Lugowski; F E Ashton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates.

Authors:  X X Gu; C M Tsai
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia.

Authors:  Kim Jemmett; Annalisa Macagno; Monica Molteni; John E Heckels; Carlo Rossetti; Myron Christodoulides
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

7.  Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokines.

Authors:  Myron Christodoulides; Benjamin L Makepeace; Kris A Partridge; Davindaur Kaur; Mark I Fowler; Roy O Weller; John E Heckels
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  Immune enhancement of pulmonary clearance of nontypable Haemophilus influenzae.

Authors:  E J Hansen; D A Hart; J L McGehee; G B Toews
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

9.  Interactions of Neisseria gonorrhoeae with mature human macrophage opacity proteins influence production of proinflammatory cytokines.

Authors:  B L Makepeace; P J Watt; J E Heckels; M Christodoulides
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.